Vision Disorders Clinical Trial
Official title:
Efficacy of Coloured Overlays and Lenses for Adults With Reading Difficulty
This is a randomised controlled trial with the aim of testing the efficacy of coloured overlays and coloured lenses for the relief of visual stress and reading difficulties in children and young adults.
Participants will be adults aged from 8 years, with symptoms of visual stress (discomfort
when reading or experiencing perceptual symptoms when reading such as letters moving or
distorted) or with a diagnosed reading difficulty (dyslexia). Participants will be recruited
from the City University London optometry clinic and the City University London Learning
Success unit. Participants within this age range and with visual stress will be eligible to
participate. Potential participants with an ocular or systemic condition with possible impact
on vision (e.g. amblyopia or diabetes respectively) or with intellectual disability will be
excluded from the study. Each potential participant will undergo an eye examination prior to
participation, during which the following tests will be conducted:
Prior to study entry:
History and symptoms Direct ophthalmoscopy (to check for ocular abnormality) Retinoscopy and
subjective refraction (to quantify corrected and uncorrected refractive error) Cover tests
(to look for any eye misalignment)
Baseline tests on study entry:
Each eligible participant who agrees to take part in the study will undergo testing with
coloured overlays, to determine whether a particular overlay appears to be beneficial in
terms of reducing difficulty or discomfort while reading. If so, the participant will be
provided with the overlay to use for a period of two weeks, to determine whether it is
consistently beneficial when reading during that period. In addition, the Wilkins Rate of
Reading Test (WRRT) will be carried out at this baseline stage with and without the overlay.
Follow-up test 1:
The participant will attend a further appointment at the two week time point, and if the
overlay was beneficial, an addition test will be carried out using the Intuitive Colorimeter,
to determine the exact hue, saturation and intensity of coloured lenses that offer the most
relief from difficulty or discomfort while reading. Once this colour has been determined, the
hue will be modified to find the closest colour at which the participant first loses benefit
(the point at which the discomfort or difficulty returns). Each colour setting (beneficial
and non-beneficial) will be noted and the participant will be provided with spectacle lenses
tinted exactly to one of these colour specifications. In a crossover design, the order in
which true or control lenses will be provided to each participant will be determined by
random number generation. Allocation will be carried out by personnel who are not researchers
on this study, and who know the order (true lens tint first or second) as 1 and 2. Ordering
of tinted spectacles will be handled by the personnel who are not researchers on the study,
and this information will not be accessible by the researchers. Thus, tinted lens ordering
will not be shared with the researchers, who will not know whether each participant is
wearing the beneficial or non-beneficial tint, and so will be masked. Similarly, participants
will be unaware whether they are wearing the true or control tint, at any time during their
participation. The non-beneficial tint will be very similar to the beneficial tint, so
neither researchers nor participants will be able to determine this. On this occasion the
participant will also be asked to describe the difficulties he/she has experiences when
reading with and without the coloured overlay.
Follow-up test 2:
After one month wearing the first pair of tinted lenses, reading speed will be measured again
with the first pair of tinted lenses, and the participant will be asked again about their
experience of reading difficulties while wearing these glasses. The participant will be asked
to spend one week without any tinted lenses, and to return for a further visit after that
week. After this period, the second pair of tinted lenses will be provided, to be worn for a
further month.
Follow-up test 3:
Reading speed will be measured again with the second pair of tinted lenses and the
participant will again be asked about their experience of reading difficulties while wearing
these glasses.
Statistical analysis The main outcome measures are rates of reading provided by the two
reading tests, with the two tinted lens types, the overlay, and without any tint. These are
quantitative tests and the results will be compared between the two groups using an unpaired
t-test, and within individuals (between baseline and follow-up tests) using a repeated
measures analysis of variance. In addition, qualitative data are obtained from participants'
descriptions of their experience of reading difficulty at different stages of the study.
These responses will be analysed using NVivo software to look for themes.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03872479 -
Single Ascending Dose Study in Participants With LCA10
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT02595502 -
Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact Lenses
|
N/A | |
Completed |
NCT02485054 -
A Predictive Score for the Ischemic Etiology of a Transient Visual Disturbances (VASCO)
|
||
Completed |
NCT00985231 -
Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers
|
N/A | |
Recruiting |
NCT05208658 -
Characteristics of the Vergence Responses of Binocularly Normal Subjects After a Vision Therapy Protocol
|
N/A | |
Recruiting |
NCT06077682 -
Cycloplegic Refraction in Pediatric Patients With Esotropia
|
Phase 4 | |
Active, not recruiting |
NCT04123626 -
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
|
Phase 1/Phase 2 | |
Recruiting |
NCT04693247 -
Handheld Device Compared With a Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction
|
N/A | |
Recruiting |
NCT06451172 -
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
|
Early Phase 1 | |
Completed |
NCT01318577 -
Study of A New Contact Lens Cleaning and Disinfecting Solution
|
N/A | |
Completed |
NCT03763721 -
The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation
|
N/A | |
Completed |
NCT05602402 -
To Evaluate the Efficacy and Safety of CAEP-01 on Eye Strain in Children With Heavy Screen Use
|
N/A | |
Not yet recruiting |
NCT06085430 -
Kubota Glass Parameter Refinement Study
|
N/A | |
Completed |
NCT04347564 -
Usability of the Software MacuFix for the Categorization of Metamorphopsia
|
||
Completed |
NCT01546402 -
Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema
|
Phase 4 | |
Completed |
NCT01698788 -
Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema
|
N/A | |
Completed |
NCT03169855 -
Validation of Mesopic and Photopic Contrast Vision Tests With Respect to Nighttime Driving Ability
|
||
Terminated |
NCT03913130 -
Extension Study to Study PQ-110-001 (NCT03140969)
|
Phase 1/Phase 2 | |
Recruiting |
NCT03479021 -
SPOT Vision Screening
|
||
Recruiting |
NCT05600140 -
Viewing Strategy Training in Children With (Cerebral) Visual Impairment
|
N/A |